| Page 2 | Kisaco Research
 
Edge AI Summit 2020
18-20 Nov 2020
VIRTUAL SUMMIT | PDT Timezone
A 2020 report by Frost & Sullivan stated that 90% of industrial enterprises will be utilising edge computing by 2022. The value of the data that can be gleaned from intelligence ‘in the field’ is clear, but the current limitations of low power, on-device compute, data management and processing across the edge computing landscape continue to pose multiple engineering challenges. We’re thrilled to announce the agenda for the 3rd annual Edge AI Summit, which was the first ever dedicated summit focused on deploying machine learning on devices, and on the network infrastructure that supports the intelligent IoT. This year is all about Edge AI case studies! From ultra-low-power microwatt applications at the ‘sensor edge’, to larger milliwatt examples at the ‘device edge’ up to the non-power constrained ‘server-network edge’; we’ll be gathering a global audience (virtually!) to explore the most innovative real-world use cases of hardware and software facilitating AI at the Edge with examples from Uber AI, Google, Bosch, Magic Leap, Rakuten and many more…
Visit Site
 
Animal Health, Nutrition and Technology Innovation Europe 2022
21-23 Feb 2022
London, UK
Now in its 7th year, Animal Health, Nutrition and Technology Innovation Europe is the sector’s premier Innovation Summit showcasing the most exciting investment opportunities globally and connecting businesses with investors and strategic corporate partners. Our mission is to engage all key participants in the value chain so we can address the full scope of how animal health impacts pet owners, veterinarians, and farmers today.Following overwhelming feedback from the market, we have significantly expanded our programme this year with new focused content on nutrition and technology, alongside our production and companion animal health content. We will be running 4 separate innovation showcases in production animal health, companion animal health, nutrition, and technology.Our new programme will address the full extent of this ever-evolving market. We are excited to provide an innovation platform that is bigger than ever and to continue to play a critical role in shaping the future of the animal health industry by presenting the most exciting innovations in prediction, prevention, and cure.Book now to come and see for yourself!
Visit Site
 

Josefina Correa

Chief Executive Officer
Xeptiva Therapeutics

Josefina Correa

Chief Executive Officer
Xeptiva Therapeutics

Josefina Correa

Chief Executive Officer
Xeptiva Therapeutics
 

Josefina Correa

Chief Executive Officer
Xeptiva Therapeutics

Josefina Correa

Chief Executive Officer
Xeptiva Therapeutics

Josefina Correa

Chief Executive Officer
Xeptiva Therapeutics
 

Dr Gary Call

Chief Medical Officer
HMS

Dr. Gary Call is a board-certified family physician and senior healthcare executive with extensive experience in managed care operations and payment integrity.

Dr. Call is nationally recognized for his leadership in payment integrity and FWA prevention, including advanced analytics, clinical review strategies, and technology-enabled solutions that protect both government and commercial payer programs from improper payments and emerging integrity risks.

Read full bio

Dr Gary Call

Chief Medical Officer
HMS

Dr Gary Call

Chief Medical Officer
HMS

Dr. Gary Call is a board-certified family physician and senior healthcare executive with extensive experience in managed care operations and payment integrity.

Dr. Call is nationally recognized for his leadership in payment integrity and FWA prevention, including advanced analytics, clinical review strategies, and technology-enabled solutions that protect both government and commercial payer programs from improper payments and emerging integrity risks.

As Chief Medical Officer at HMS, Dr. Call oversees Payment Integrity, Care Management, Clinical Analytics, and Population Health Solutions, driving innovation and clinical programs that improve outcomes, strengthen program integrity, and support the financial sustainability of state healthcare programs.

 

Jordan D. Grotzinger

Shareholder
Greenberg Traurig, LLP

Jordan D. Grotzinger

Shareholder
Greenberg Traurig, LLP

Jordan D. Grotzinger

Shareholder
Greenberg Traurig, LLP
 

Gregory Bombard

Shareholder
Greenberg Traurig, LLP

Gregory Bombard

Shareholder
Greenberg Traurig, LLP

Gregory Bombard

Shareholder
Greenberg Traurig, LLP

The industry's payment integrity ambitions, from earlier intervention to automation and smarter clinical review, all assume a data foundation most plans do not yet have. This session works backwards from where the industry is heading to examine what has to be true underneath.

  • Why fragmented, inconsistent data caps the ROI of every downstream PI investment
  • Bringing structured and unstructured data, including charts, PDFs, and clinical documentation, into a single usable foundation

In partnership with Abacus Insights

 

Christopher J. Burke

Magistrate Judge
U.S. District Court for the District of Delaware

Christopher J. Burke

Magistrate Judge
U.S. District Court for the District of Delaware

Christopher J. Burke

Magistrate Judge
U.S. District Court for the District of Delaware